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The  RCK gene was cloned through the study of the
t(11;14)(q23;q32) translocation observed in human B-cell
lymphoma cell line RC-K8 (Akao et al, 1991). This gene was found
to have been broken at its first intron and fused to an immuno-
globulin heavy chain gene (IgH) by a t(11;14) translocation. Its
protein (rck/p54) belongs to the DEAD box (D-E-A-D is the single
letter code of Asp-Glu-Ala-Asp) protein/RNA helicase family,
which has a variety of functions such as translation initiation, pre-
mRNA splicing and ribosome assembly (Akao et al, 1992). The
rck/p54 protein of 472 amino acids is a 54-kDa cytoplasmic protein
and is overexpressed due to the fusion to the IgH gene in the same
manner as c-myc in t(8;14) or bcl-2 in t(14;18) (Rabbitts, 1994;
Akao et al, 1995). Moreover, we previously found that the expres-
sion of rck/p54 is very poor in brain, skeletal muscle and lung
tissues, but is significant in tumours that originated from these
tissues (Akao et al, 1995). These findings suggest that rck/p54 may
be linked to cell proliferation and malignant transformation.
Recently, the Xenopus rck/p54 homologue Xp54, which is
homologous to rck/p54 by 94%, was shown to possess RNA
helicase activity. It was speculated that Xp54 may be necessary for
the efficient translational recruitment of stored mRNA or enhance
translation of mRNA at a time when large quantities of product are
required in Xenopus oogenesis (Ladomery et al, 1997). It was
considered that some of the DEAD box protein/RNA helicase
family work on mRNAs, which have stem and loop tertiary struc-
ture, and make them change to straight resulting in facilitation of
translation. The best characterized DEAD box protein, eIF-4A plays
a central role in translation initiation together with two other factors,
p220 and the cap-binding protein eIF-4E. In cells, eIF-4A exists in a
free form or in the eIF-4F complex, which complex interacts with
mRNA to facilitate its translation (Rosen et al, 1990). It was also
reported that Ded1p, a yeast DEAD box protein, is required for the
initial step of translation (Chuang et al, 1997). Thus, rck/p54
supposedly facilitates the translation of mRNA(s) of genes for cell
proliferation and malignant transformation.
Based on these findings, we examined the expression of rck/p54
protein in the colorectal tumours by immunohistochemistry and
Western blot analysis. It is of interest that we found rck/p54 to be
overexpressed in approximately 54% of the colorectal tumours
studied.
MATERIALS AND METHODS
Tissue preparation
All human tissue samples (primary colorectal adenocarcinoma,
adjacent normal colorectal mucosa from specimens resected for
carcinoma and adenoma) were specimens obtained with informed
consent from patients who were undergoing surgical operations
or biopsies at Osaka Medical College, Takatsuki, Osaka, between
1996 and 1998. We examined 26 cases of colorectal adenocarci-
nomas and two cases of colonic adenomas (severe dysplasia). All
tissues were divided into cancerous and normal parts. For each
tissue sample, a small part was applied for Western blot analysis,
and the remainder was fixed in 10% buffered formaldehyde solu-
tion and embedded in paraffin. For immunohistochemical study,
five series of 4-mm-thick sections were prepared. One section was
stained with haematoxylin and eosin and reviewed by two pathol-
ogists to confirm the diagnosis including pathological prognostic
factors such as tumour type, size and stage. The other sections
were used for analysing the expression of rck/p54 and mutant p53
proteins. Table 1 shows the clinical characteristics of the 28 cases
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tested, including Dukes¢ staging system, differentiation grade and
types of growth.
Immunohistochemical staining
The 4-mm sections from paraffin-enbedded tissues were mounted
on poly-L-lysine-coated slides. They were then deparaffinized in
xylene and dehydrated with graded ethanol. Endogenous peroxi-
dase activity was blocked with 0.2% (w/v) sodium azide
containing in 0.3% (v/v) hydrogen peroxide in graded methanol
for 60 min. In the case of rck/p54 protein, after having been
washed in 0.01 M phosphate-buffered saline (PBS), the section
was blocked for non-specific binding with Avidin/Biotin Blocking
solution (Vector Laboratories, Inc., CA, USA). The sections were
then incubated with rabbit polyclonal anti-rck/p54 antibody
diluted at 1:200 in a moist chamber overnight at 4°C. In the case of
p53 protein, the sections were incubated with anti-p53 monoclonal
antibody (BP53-12, Japan Tarner, Ltd., Osaka, Japan) diluted at
1:25. After having been washing in 0.01 M PBS, the sections were
subsequently incubated for 30 min at room temperature with
biotinylated goat anti-rabbit immunoglobulin and biotinylated
goat anti-mouse immunoglobulin for rck/p54 and p53 protein
expression respectively. After another wash in PBS, peroxidase-
conjugated avidin (Vector Stain Elite ABC Kit, Vector
Laboratories, Inc., CA, USA) was applied, and the sections were
again incubated for 30 min. In both cases, after washing out of the
excess complex, the localization of immunoreactive complexes
was visualized by incubation of the sections for 5–10 min in 0.05
M Tris–HCl (pH 7.6) containing 0.02% (w/v) 3-3¢-diaminobenzi-
dine tetrahydrochloride and 0.03% (v/v) hydrogen peroxide. A
negative control section, to which normal rabbit preimmune serum
was applied in slides for rck/p54 expression, was included in each
staining. Counter staining was performed with haematoxylin.
Western blot analysis
Fresh tissues were homogenized in lysis buffer (2 ´ PBS, 0.1%
sodium dodecyl sulphate (SDS), 1% Nonidet P-40, 0.5% sodium
deoxychlorate, and 0.1 mM phenylmethanesulphonyl fluoride). The
homogenized samples were centrifuged, and the clear supernatant
was used as protein lysate. The protein concentration was determined
by the method of Markwell et al (1981). Ten micrograms of lysate
protein was separated by SDS polyacrylamide gel electrophoresis
(SDS-PAGE) using a 10% polyacrylamide gel and electroblotted
onto a polyvinylidene difluoride membrane (Du Pont, Boston, MA,
USA). After blockage of non-specific binding sites for 1 h with 5%
non-fat milk in TPBS (PBS and 0.1% Tween-20), the membrane was
incubated overnight at 4°C with anti-human rck/p54 antibody (Akao
et al, 1995) at a dilution of 1:300. The membrane was then washed
three times with TPBS, incubated further with alkaline phosphatase-
conjugated goat anti-rabbit antibody (New England Biolabs, Beverly,
MA, USA) at room temperature, and then washed three times with
Table 1 Immunohistochemical expression of rck/p54 and p53 and clinicopathologic features
Immunohistochemical staining
Case Age Sexa Sizeb Depthc Sited Stagee Growthf p53g rck/p54h
O-1 73 M 12 SM R A PG D –
O-2 50 M 5 SM S A NPG D –
O-3 44 M 5 SM R A NPG – –
O-4 56 M 12 SM R A PG D 2+
O-5 38 M 11 SM T A PG – –
O-6 74 M 7 SM T A NPG – 1+
O-8 43 M 23 SM R C NPG D 1+
O-11 73 M 8 SM S A PG D –
O-14 65 F 10 SM S A PG D 2+
O-16 64 M 18 SM S A PG – 1+
O-20 81 M 22 SM T A PG – –
O-24 67 M 20 SM R A PG – –
O-26 82 M 7 SM R A PG D 1+
O-31 64 M 20 SM A A PG – –
O-33 60 M 25 SM R A PG D 2+
O-34 61 F 27 SM R A PG – 1+
O-35 69 M 4 SM R A NPG FD –
O-40 66 M 8 SM S C NPG FD 2+
O-42 70 F 18 SM D C PG – 1+
O-43 54 M 13 SM A C NPG – –
O-44 80 M 26 SM D C NPG – –
O-45 57 M 17 SM S C NPG D 2+
O-46 64 M 10 SM S A NPG FD –
O-71 64 F 59 MP T A 2 D 1+
O-72 53 F 27 MP R A 2 D –
O-79 65 M 30 MP R A 2 – 1+
O-80 53 F 16 M A A PG – 2+
O-81 53 F 22 M C A PG – 1+
aM, Male; F, female. bDiameter in mm. cM, adenoma (severe dysplasia); SM, submucosa; MP, muscularis propria. dLocation of tumour; C, caecum; A, ascending
colon; T, transverse colon; D, descending colon; S, sigmoid colon; R, rectum. eDukes’ system. fGrowth type: PG, polypoid growth; NPG, non-polypoid growth; 2,
2type advanced cancer. gD, diffuse; FD, focal diffuse; –, no overexpression. hOverexpression; 2+, positive (tumour » normal); 1+, positive (tumour > normal
mucosa); –, no overexpression.916 Y Nakagawa et al
British Journal of Cancer (1999) 80(5/6), 914–917 © Cancer Research Campaign 1999
TPBS. The immunoblot was visualized by use of an enhanced
chemiluminescence detection kit (New England Biolabs).
RESULTS
The histopathological findings on 28 tissue samples of colorectal
tumours that were examined immunohistochemically are summa-
rized in Table 1. The median age of the 28 patients was 64 years
(range 38–82 years old), and the subjects included 21 men and
seven women. None had received radiation or chemotherapy prior
to resection. rck/p54 overexpression was classified into two grades
as 1+ or 2+. In 15 (54%) out of the 28 samples, rck/p54 was found
to be overexpressed in adenocarcinoma and adenoma cells in
comparison with its level in the normal tissue neighbouring the
tumour in the same specimen (Table 1 and Figure 1 A–C). rck/p54
protein was found to be overexpressed in two cases (O-80 and
O–81) of severe dysplastic adenomas. The correlation between
rck/p54 expression and progression or types of cancers was not
clear (Table 1). In normal tissues from the same samples, only a
minute amount of rck/p54 was detected in the glandular cells of
crypts; whereas free histiocytes, ganglion nerve cells and infil-
trating lymphocytes were stained moderately. In both cases,
rck/p54 displayed fine granular staining in the cytoplasm of the
cells, which finding is in good agreement with the result of
immunocytology of B-cells by laser microscopic analysis (Figure
1 B,C) (Akao et al, 1995). To examine the relationship between
rck/p54 and mutant p53 protein (Finlay et al, 1988) in terms of
expression, we also performed an immunohistochemical study on
p53 protein in the O-33 specimen (Figure 1 C,D). Although the
expression of mutant p53 protein did not correlate with that of
rck/p54, taking all cases into account (Table 1), in five of the six
rck/p54-positive (2+) cases, mutant p53 protein was detected.
To confirm the results of an immunohistochemical study on
rck/p54, we performed Western blot analysis in four rck/p54-
positive cases, viz. O-16, 33, 40 and 80. The quantative difference
in rck/p54 expression was shown clearly between the homogenates
prepared from normal and tumour tissues from each patient
(Table 1 and Figure 2).
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Figure 1 Immunohistochemical staining of a human colorectal adenocarcinoma specimen (O-33) with anti-rck/p54 or anti-p53 antibody. (A) Normal colorectal
mucosa from patient O-33 reacted with preimmune rabbit serum as a control. (B) Normal colorectal mucosa stained with anti-rck/p54 antibody. Note that faint
rck/p54-specific staining is detectable on the basal side of glandular cells and in scattered cells such as histiocytes and fibroblasts in the mucosa. Arrowheads
indicate the stromal rck/p54-staining cells. (C) Adenocarcinoma specimen stained with anti-rck/p54 antibody. It is evident that the adenocarcinoma cells that
have deeply invaded are more intensely stained than normal cells in the mucosal region of (B). (D) Adenocarcinoma specimen stained with anti-p53 antibody.
The nuclei of adenocarcinoma cells are diffusely stainedOverexpression of rck/p54 in colon tumours 917
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DISCUSSION
The present study demonstrated that rck/p54, a human DEAD
box/RNA helicase protein, was overexpressed in approximately
54% of 28 cases of colorectal tumours studied by immunohisto-
chemical analysis. Earlier, we reported that the RCK mRNA was
shown to be expressed ubiquitously as judged from Northern blot
analysis but that the amount of rck/p54 protein was translationaly
regulated (Akao et al, 1995). In the brain, skeletal muscle and lung
tissues, the expression of the protein was very low; but malignant
cell lines that originated from these tissues, such as neuro-
blastoma, rhabdomyosarcoma and lung cancer cell lines, showed
marked expression of it (Akao et al, 1995). Our findings on
colorectal adenocarcinomas and adenomas are in good agreement
with those on the expression pattern in those malignant cell lines.
It is significant that the overexpression of rck/p54 was verified in
the samples from patients with colorectal tumours. rck/p54 (2+)
overexpression may be associated with mutant p53 protein (Finlay
et al, 1988) expression, because five of the six rck/p54 (2+) cases
expressed mutant p53 protein. It is of interest that rck/p54 was
overexpressed in two cases of severe dysplastic adenomas. This
finding suggests that rck/p54 may work at the early stage of malig-
nant transformation. Based on these findings, rck/p54 of a DEAD
box protein may possibly contribute to cell proliferation and
carcinogenesis by facilitating the translation of some oncogene(s)
or growth-associated gene(s) in colorectal tumours.
The DEAD box protein MrDb was reported to be one of the
target proteins of the c-myc gene that positively functions in cell
proliferation (Grandori et al, 1996). One possibility is that rck/p54
may be associated with the translation of mRNA from oncogenes
such as c-myc, E1A, or other growth-related genes. We are now in
the process of examining c-myc expression in the above samples
of colorectal tumours.
It was reported that the overexpression of eIF-4E, which is a
translation initiation factor forming a ternary complex with the
eIF-4A DEAD box protein and p220, caused cell proliferation and
malignant transformation (Lazaris-Karatzas et al, 1990). However,
although the mechanism by which rck/p54 plays a role in transfor-
mation is not clear, it is postulated that high levels of rck/p54 may
lead to the translation of mRNAs that are normally translationally
repressed. Our finding suggests that the overexpression of rck/p54
could contribute to cell proliferation and malignant transformation
at the translational level. It is still to be determined what gene(s) is
facilitated in terms of translation of its mRNA as a step toward
carcinogenesis.
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Figure 2 Western blot analysis of rck/p54 in human colorectal normal
mucosa and tumours. Ten micrograms of protein was electrophoresed on a
10% SDS-polyacrylamide gel. N indicates normal mucosal tissues of patients
O-16, 33, 40 and 80 respectively; and T in matched samples from four
patients indicates tumour tissues of patients O-16, 33, 40 and 80
respectively. O-80 is the only case of severe dysplastic adenoma. Note that
the anti-rck/p54 antibody recognizes a 54-kDa molecule